𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Bispecific antibody targeting of doxorubicin to carcinoembryonic antigen–expressing colon cancer cell lines in vitro and in vivo

✍ Scribed by C.H.J. Ford; P.A. Osborne; B.G. Rego; A. Mathew

Publisher
John Wiley and Sons
Year
2001
Tongue
French
Weight
120 KB
Volume
92
Category
Article
ISSN
0020-7136

No coin nor oath required. For personal study only.

✦ Synopsis

A bispecific monoclonal antibody (BsMAb) recognising carcinoembryonic antigen (CEA) and doxorubicin (Dox) was used in colorimetric microcytotoxicity assays with 3 human colon cancer cell lines (COLO320DM, SKCO1 and LS174T) showing no, high or medium CEA expression, respectively. The IC50 values for Dox with COLO320DM, SKCO1 and LS174T were 1,163, 28.5 and 324 ng/ml, respectively. BsMAb caused statistically significant reductions in Dox IC50 values at 1, 0.1 and 0.01 microg/ml with the CEA-expressing cell lines SKCO1 and LS174T but not with COLO320DM. BsMAb or control antibody alone had no significant effect on the cell viability of any of the cell lines and did not reduce Dox IC50 values. In vivo, there was a statistically significant inhibition of the growth of CEA-expressing LS174T cells growing as xenografts in nude mice treated with BsMAb and Dox compared to control mice. This effect was not seen with COLO320DM xenografts. Our results demonstrate that a BsMAb that recognises CEA and Dox can reduce the IC50 for Dox in vitro and inhibit growth in vivo in a CEA-specific manner.

📜 SIMILAR VOLUMES

Carcinoembryonic antigen expression, ant
Carcinoembryonic antigen expression, antibody localisation and immunophotodetection of human colon cancer liver metastases in nude mice: A model for radioimmunotherapy
✍ Charles-André Vogel; Marie C. Galmiche; Patrick Westermann; Lin-Quan Sun; André 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 French ⚖ 982 KB

Colorectal cancer frequently disseminates through the portal vein into the liver. In this study, outbred Swiss nude mice were adapted to facilitate the induction of liver metastases by a pre-grafting treatment with 6 Gy total body irradiation and i.v.

Selective antibody-mediated targeting of
Selective antibody-mediated targeting of class I MHC to EGFR-expressing tumor cells induces potent antitumor CTL activity in vitro and in vivo
✍ Hila Novak; Roy Noy; Kfir Oved; Dina Segal; Winfried S. Wels; Yoram Reiter 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 French ⚖ 276 KB 👁 1 views

## Abstract Epidermal growth factor receptor (EGFR) is highly overexpressed in many tumor types. We present a new fusion molecule that can target solid tumors that express EGFR. The fusion molecule combines the advantage(s) of the well‐established tumor targeting capabilities of high affinity recom

Treatment of colon and breast carcinoma
Treatment of colon and breast carcinoma cells with 5-fluorouracil enhances expression of carcinoembryonic antigen and susceptibility to HLA-A(*)02.01 restricted, CEA-peptide-specific cytotoxic T cells in vitro
✍ Pierpaolo Correale; Angelo Aquino; Antonio Giuliani; Monia Pellegrini; Lucia Mic 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 French ⚖ 155 KB 👁 1 views

## Abstract Cancer vaccines directed against tumor associate antigen (TAA) have produced encouraging results in preclinical models but not in cancer patients. A major limitation of this strategy is the relative degree of tolerance to these antigens and the low and heterogeneous tumor cell expressio

In vitro response of a human colon tumor
In vitro response of a human colon tumor xenograft and a lung adenocarcinoma cell line to α-difluoromethylornithine alone and in combination with 5-fluorouracil and doxorubicin
✍ Karimullah A. Zirvi; Umur Atabek 📂 Article 📅 1991 🏛 John Wiley and Sons 🌐 English ⚖ 455 KB

We have investigated effects of a-difluoromethylornithine (DFMO), both as a single agent and in combination with 5-fluorouracil (5-FU) against a human colon tumor xenograft (T6) grown as primary tissue culture in serum-free medium and in combination with doxorubicin (DX) against a human lung adenoca